Effect of Vitamin D3 and Omega-3FA on Leptin and HbA1C With Vitamin D Deficiency
- Conditions
- Vitamin D Deficiency
- Interventions
- Dietary Supplement: omega 3 FA groupDietary Supplement: VD3 and omega- 3FA groupOther: control groupDietary Supplement: VD3 group
- Registration Number
- NCT03735303
- Lead Sponsor
- Applied Science Private University
- Brief Summary
The Combined effect of Vitamin D3 and Omega-3 supplements on serum leptin and Glycated hemoglobin (Hb A1C) levels in Jordanian people with vitamin D deficiency.
- Detailed Description
Nothing is published in the literature about effect of vitamin D3 (VD3) and omega-3 fatty acids (omega-3FA) on serum leptin and glycated hemoglobin ( HbA1C)
This study will be conducted to investigate effect of VD3 and omega-3FA alone and with each other on serum leptin and Glycated hemoglobin (Hb A1C) levels in Jordanian people with vitamin D deficiency.
This randomized, controlled clinical trial will be designed to test effects of 50,000 IU VD3 weekly and 1000 mg omega-3FA daily for eight weeks, separately and with each other, on on serum leptin and Glycated hemoglobin (Hb A1C) levels .
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 146
- jordanian people aged 25-55
- medical diagnosis of vitamin D deficiency ( VD <25 ng/ ml)
- Blood disorders including
- thalassemia
- sickle cell disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description omega 3- FA group omega 3 FA group dietary supplement : omega 3- FA group 1000 mg wild salmon and fish oil complex (contain 300 mg of omega 3-FA) once daily for 8 weeks VD3 and omega 3 FA group VD3 and omega- 3FA group dietary supplement : VD3 and omega-3FA 50000 IU VD3/week for 8 weeks and 1000 mg wild salmon and fish oil complex (contain 300 mg of omega 3-FA) once daily for 8 weeks control group control group no intervention was given VD3 group VD3 group dietary supplement : VD3 group treated with 50000 IU VD3/ week for 8 weeks
- Primary Outcome Measures
Name Time Method HbA1C 8 weeks plasma concentration of HbA1C
leptin 8 weeks serum level of leptin
VD 3 8 weeks Serum level of 25-hydroxyvitamin D
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Applied Science University
🇯🇴Amman, Jordan